MedTrace Logo

Low Level Laser Therapy to Reduce Pain After Breast Augmentation Surgery

NCT00926887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 104

Last updated 2014-04-17

Study results available
· View outcomes & findings →

Summary

The goal of the clinical study was to see if applying low level laser light therapy to the breasts during breast implant surgery could lessen pain experienced by 24 hours after the surgery.

Conditions

Interventions

DEVICE

Erchonia(R) EML Laser

Low level laser red light of 635 nm and delivering 1.5 joules/cm2.

DEVICE

Placebo Laser

Inactive light

Sponsors & Collaborators

  • Erchonia Corporation

    lead INDUSTRY

Principal Investigators

  • Robert F Jackson, MD, FACS

  • Gregory Roche, DO

  • Thomas L Jackson, MD

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2007-07-31
Completion
2007-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00926887 on ClinicalTrials.gov